Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia; Department of Medicine, University of Melbourne, Melbourne, VIC, Australia; Department of Gastroenterology, St Vincent's Hospital Melbourne, VIC, Australia.
Lancet Gastroenterol Hepatol. 2020 Oct;5(10):927-939. doi: 10.1016/S2468-1253(20)30010-8. Epub 2020 Jul 27.
WHO has set global targets for the elimination of hepatitis B and hepatitis C as a public health threat by 2030. However, investment in elimination programmes remains low. To help drive political commitment and catalyse domestic and international financing, we have developed a global investment framework for the elimination of hepatitis B and hepatitis C. The global investment framework presented in this Health Policy paper outlines national and international activities that will enable reductions in hepatitis C incidence and mortality, and identifies potential sources of funding and tools to help countries build the economic case for investing in national elimination activities. The goal of this framework is to provide a way for countries, particularly those with minimal resources, to gain the substantial economic benefit and cost savings that come from investing in hepatitis C elimination.
世界卫生组织设定了在 2030 年前消除乙型和丙型肝炎这一公共卫生威胁的全球目标。然而,消除规划的投资仍然很低。为了帮助推动政治承诺并促进国内和国际供资,我们制定了一个消除乙型和丙型肝炎的全球投资框架。本卫生政策文件介绍的全球投资框架概述了将减少丙型肝炎发病率和死亡率的国家和国际活动,并确定了潜在的供资来源和工具,以帮助各国建立投资于国家消除活动的经济案例。该框架的目标是为各国,特别是资源有限的国家,提供一种途径,让它们从投资于消除丙型肝炎中获得巨大的经济效益和成本节约。